Viracta Therapeutics, Inc. Quarterly Interest Expense in USD from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Viracta Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2011 to Q3 2024.
  • Viracta Therapeutics, Inc. Interest Expense for the quarter ending September 30, 2024 was $679K, a 28.8% decline year-over-year.
  • Viracta Therapeutics, Inc. Interest Expense for the twelve months ending September 30, 2024 was $3.18M, a 8.26% increase year-over-year.
  • Viracta Therapeutics, Inc. annual Interest Expense for 2023 was $3.7M, a 542% increase from 2022.
  • Viracta Therapeutics, Inc. annual Interest Expense for 2022 was $577K, a 17.5% increase from 2021.
  • Viracta Therapeutics, Inc. annual Interest Expense for 2021 was $491K, a 127% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $3.18M $679K -$274K -28.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $3.46M $697K -$224K -24.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $3.68M $858K -$22K -2.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $3.7M $950K +$763K +408% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $2.94M $953K +$814K +586% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $2.13M $921K +$794K +625% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $1.33M $880K +$756K +610% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $577K $187K +$48K +34.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $529K $139K +$14K +11.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $515K $127K +$5K +4.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $510K $124K +$19K +18.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $491K $139K +$54K +63.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 $437K $125K +$59K +89.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $378K $122K +$57K +87.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $321K $105K +$105K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $216K $85K +$485K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$269K $66K -$5K -7.04% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$264K $65K -$46K -41.4% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-11
Q1 2020 -$218K $0 -$261K -100% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $42.8K -$400K -$695K -236% Oct 1, 2019 Dec 31, 2019 8-K/A 2021-03-23
Q3 2019 $738K $71K -$220K -75.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $958K $111K -$176K -61.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $1.13M $261K -$20K -7.12% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $1.15M $295K +$15K +5.36% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 $1.14M $291K +$3K +1.04% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $1.14M $287K -$57K -16.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $1.19M $281K -$203K -41.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $1.4M $280K -$194K -40.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 $1.59M $288K -$185K -39.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 $1.78M $344K -$132K -27.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $1.91M $484K +$186K +62.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $1.72M $474K +$240K +103% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-09
Q3 2016 $1.48M $473K +$240K +103% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $1.24M $476K +$243K +104% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-27
Q1 2016 $998K $298K +$59K +24.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $939K $234K -$77K -24.8% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-09
Q3 2015 $1.02M $233K -$158K -40.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $1.17M $233K -$237K -50.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-29
Q1 2015 $1.41M $239K -$308K -56.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $1.72M $311K -$312K -50.1% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-09
Q3 2014 $2.03M $391K -$304K -43.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $2.34M $470K -$298K -38.8% Mar 31, 2014 Jun 30, 2014 10-Q 2015-07-30
Q1 2014 $2.63M $547K -$284K -34.2% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 $2.92M $623K -$216K -25.7% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-14
Q3 2013 $3.13M $695K +$310K +80.5% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $2.82M $768K +$452K +143% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $2.37M $831K +$516K +164% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 $1.86M $839K Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 $385K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $316K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-02
Q1 2012 $315K +$315K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q1 2011 $0 Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.